- Home
- Publications
- Publication Search
- Publication Details
Title
Multi-modality management of hypertrophic cardiomyopathy
Authors
Keywords
-
Journal
Hospital practice (1995)
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2023-01-04
DOI
10.1080/21548331.2022.2162297
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
- (2022) Mengyao Zhou et al. JAMA Cardiology
- Endocardial Radiofrequency Ablation vs. Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis
- (2022) Tao Jiang et al. Frontiers in Surgery
- Transcatheter Myotomy to Treat Hypertrophic Cardiomyopathy and Enable Transcatheter Mitral Valve Replacement: First-in-Human Report of Septal Scoring Along the Midline Endocardium
- (2022) Adam B. Greenbaum et al. Circulation-Cardiovascular Interventions
- Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside
- (2022) Chiara Palandri et al. DRUGS
- Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
- (2022) Milind Y. Desai et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Targeting Alcohol Septal Ablation in Patients with Obstructive Hypertrophic Cardiomyopathy Candidates for Surgical Myectomy: Added Value of Three-Dimensional Intracoronary Myocardial Contrast Echocardiography
- (2021) Giovanni La Canna et al. Journal of Clinical Medicine
- Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy
- (2021) Chihyuan Chuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Age‐related survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy
- (2021) Angelika Batzner et al. ESC Heart Failure
- Impact of cibenzoline treatment on left ventricular remodelling and prognosis in hypertrophic obstructive cardiomyopathy
- (2021) Mareomi Hamada et al. ESC Heart Failure
- Hypertrophic cardiomyopathy: the future of treatment
- (2020) C. Vaughan Tuohy et al. EUROPEAN JOURNAL OF HEART FAILURE
- Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 Years
- (2020) Alejandro Lemor et al. AMERICAN JOURNAL OF CARDIOLOGY
- Abnormalities in Sodium Current and Calcium Homeostasis as Drivers of Arrhythmogenesis in Hypertrophic Cardiomyopathy
- (2020) Raffaele Coppini et al. CARDIOVASCULAR RESEARCH
- Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy
- (2020) Carolyn Y. Ho et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Iacopo Olivotto et al. LANCET
- Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
- (2020) Ibadete Bytyçi et al. Journal of Clinical Medicine
- Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations
- (2019) James A. Spudich PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy
- (2019) Stephen B. Heitner et al. ANNALS OF INTERNAL MEDICINE
- Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a contemporary reappraisal
- (2019) Francesco Pelliccia et al. EuroIntervention
- Late sodium current inhibitors to treat exercise-induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium
- (2018) Cecilia Ferrantini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy
- (2018) Iacopo Olivotto et al. Circulation-Heart Failure
- Rationale and design of the TRICHAMPION trial: Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy Patients
- (2018) Antonio Berruezo et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score–matched cohort
- (2018) Anita Nguyen et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Transcatheter Mitral-Valve Repair in Patients with Heart Failure
- (2018) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers
- (2018) Robert L. Anderson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis
- (2018) Mohammed Osman et al. CLINICAL CARDIOLOGY
- Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy
- (2018) Liwen Liu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Altered Ca2+ and Na+ Homeostasis in Human Hypertrophic Cardiomyopathy: Implications for Arrhythmogenesis
- (2018) Raffaele Coppini et al. Frontiers in Physiology
- A small-molecule modulator of cardiac myosin acts on multiple stages of the myosin chemomechanical cycle
- (2017) Raja F. Kawas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations
- (2017) Suman Nag et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations
- (2017) Suman Nag et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
- (2017) Shi Sum Poon et al. Interactive Cardiovascular and Thoracic Surgery
- Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy
- (2017) Masataka Kawana et al. Science Advances
- MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy
- (2017) James W. McNamara et al. PLoS One
- Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy
- (2016) Iacopo Olivotto et al. Circulation-Heart Failure
- Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry
- (2016) Josef Veselka et al. EUROPEAN HEART JOURNAL
- Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives
- (2016) Enrico Ammirati et al. EUROPEAN JOURNAL OF HEART FAILURE
- Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy
- (2016) Elisa Passini et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
- (2016) Paul Sorajja et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
- (2016) E. M. Green et al. SCIENCE
- Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin
- (2016) Arjun S. Adhikari et al. Cell Reports
- Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy
- (2016) Luke K. Kim et al. JAMA Cardiology
- Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography
- (2015) P. Patel et al. Circulation-Cardiovascular Imaging
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
- (2015) Silvia G. Priori et al. EUROPEAN HEART JOURNAL
- Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug
- (2015) Nathan J. Verlinden et al. PHARMACOTHERAPY
- Hypertrophic and Dilated Cardiomyopathy: Four Decades of Basic Research on Muscle Lead to Potential Therapeutic Approaches to These Devastating Genetic Diseases
- (2014) James A. Spudich BIOPHYSICAL JOURNAL
- Surgical Septal Myectomy Versus Alcohol Septal Ablation
- (2014) Barry J. Maron et al. CIRCULATION
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
- (2014) EUROPEAN HEART JOURNAL
- 94 Percutaneous Mitral Repair in Hypertrophic Cardiomyopathy: Abstract 94 Table 1
- (2014) Antonis Pantazis et al. HEART
- MitraClip Implantation as a New Treatment Strategy against Systolic Anterior Motion-induced Outflow Tract Obstruction in Hypertrophic Obstructive Cardiomyopathy
- (2014) Ulrich Schäfer et al. Heart Lung and Circulation
- Periprocedural Complications and Long-Term Outcome After Alcohol Septal Ablation Versus Surgical Myectomy in Hypertrophic Obstructive Cardiomyopathy
- (2014) Robbert C. Steggerda et al. JACC-Cardiovascular Interventions
- Advances in medical treatment of hypertrophic cardiomyopathy
- (2014) Mareomi Hamada et al. Journal of Cardiology
- Percutaneous Mitral Valve Repair for Mitral Regurgitation in High-Risk Patients
- (2014) Donald D. Glower et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy
- (2013) Jan Krejci et al. TheScientificWorldJOURNAL
- Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy
- (2012) Paul Sorajja et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
- (2012) Paul Sorajja et al. CIRCULATION
- Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy
- (2012) Raffaele Coppini et al. CIRCULATION
- Interventional Treatments for Hypertrophic Cardiomyopathy
- (2011) Saidi A. Mohiddin et al. Cardiovascular Therapeutics
- Endocardial Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy
- (2011) Thorsten Lawrenz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Hypertrophic Cardiomyopathy
- (2010) Carolyn Y. Ho Heart Failure Clinics
- The Many Faces of Hypertrophic Cardiomyopathy: From Developmental Biology to Clinical Practice
- (2009) Iacopo Olivotto et al. Journal of Cardiovascular Translational Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started